191 related articles for article (PubMed ID: 6120952)
1. Evidence for an augmented glucagon dependence of hepatic glucose production in cirrhosis of the liver.
Keller U; Sonnenberg GE; Burckhardt D; Perruchoud A
J Clin Endocrinol Metab; 1982 May; 54(5):961-8. PubMed ID: 6120952
[TBL] [Abstract][Full Text] [Related]
2. Insulin-glucagon interaction in controlling splanchnic glucose production in normal man.
Bomboy JD; Lewis SB; Sinclair-Smith BC; Lacy WW; Liljenquist JE
J Clin Endocrinol Metab; 1977 Mar; 44(3):474-80. PubMed ID: 838848
[TBL] [Abstract][Full Text] [Related]
3. Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man.
Liljenquist JE; Mueller GL; Cherrington AD; Keller U; Chiasson J-L ; Perry JM; Lacy WW; Rabinowitz D
J Clin Invest; 1977 Feb; 59(2):369-74. PubMed ID: 833282
[TBL] [Abstract][Full Text] [Related]
4. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects.
Sonnenberg GE; Keller U; Perruchoud A; Burckhardt D; Gyr K
Gastroenterology; 1981 Mar; 80(3):526-32. PubMed ID: 6108898
[TBL] [Abstract][Full Text] [Related]
5. Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man.
Liljenquist JE; Mueller GL; Cherrington AD; Perry JM; Rabinowitz D
J Clin Endocrinol Metab; 1979 Jan; 48(1):171-5. PubMed ID: 422700
[TBL] [Abstract][Full Text] [Related]
6. Role of basal glucagon levels in the regulation of splanchnic glucose output and ketogenesis in insulin-deficient humans.
Björkman O; Felig P; Wahren J
Clin Physiol; 1984 Jun; 4(3):227-41. PubMed ID: 6146427
[TBL] [Abstract][Full Text] [Related]
7. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
[TBL] [Abstract][Full Text] [Related]
8. Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: relationship to glucagon.
Hamberg O; Vilstrup H
Hepatology; 1994 Jan; 19(1):45-54. PubMed ID: 7903954
[TBL] [Abstract][Full Text] [Related]
9. Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans.
Wahren J; Efendić S; Luft R; Hagenfeldt L; Björkman O; Felig P
J Clin Invest; 1977 Feb; 59(2):299-307. PubMed ID: 833277
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin does not alter insulin-mediated glucose disposal.
Meneilly GS; Elahi D; Minaker KL; Rowe JW
J Clin Endocrinol Metab; 1987 Aug; 65(2):364-7. PubMed ID: 2885337
[TBL] [Abstract][Full Text] [Related]
11. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
Baron AD; Schaeffer L; Shragg P; Kolterman OG
Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
[TBL] [Abstract][Full Text] [Related]
12. Effect of somatostatin (SRIF) on plasma glucose and insulin response to glucagon in liver cirrhosis.
Altomonte L; Greco AV; Ghirlanda G; Rebuzzi AG; Manna R; Bertoli A
Acta Diabetol Lat; 1979; 16(2):139-45. PubMed ID: 484163
[TBL] [Abstract][Full Text] [Related]
13. Restoration of stable metabolic conditions during islet suppression in dogs.
Bradley DC; Bergman RN
Am J Physiol; 1992 Apr; 262(4 Pt 1):E532-8. PubMed ID: 1348903
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow.
Nosadini R; Avogaro A; Mollo F; Marescotti C; Tiengo A; Duner E; Merkel C; Gatta A; Zuin R; de Kreutzenberg S
J Clin Endocrinol Metab; 1984 Jun; 58(6):1125-32. PubMed ID: 6373811
[TBL] [Abstract][Full Text] [Related]
15. Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver.
Shankar TP; Fredi JL; Himmelstein S; Solomon SS; Duckworth WC
Am J Med Sci; 1986 Apr; 291(4):248-54. PubMed ID: 3518447
[TBL] [Abstract][Full Text] [Related]
16. Selective suppression of hepatic glucose output by human proinsulin in the dog.
Lavelle-Jones M; Scott MH; Kolterman O; Rubenstein AH; Olefsky JM; Moossa AR
Am J Physiol; 1987 Feb; 252(2 Pt 1):E230-6. PubMed ID: 2881485
[TBL] [Abstract][Full Text] [Related]
17. Regulation of glucose homeostasis in humans with denervated livers.
Perseghin G; Regalia E; Battezzati A; Vergani S; Pulvirenti A; Terruzzi I; Baratti D; Bozzetti F; Mazzaferro V; Luzi L
J Clin Invest; 1997 Aug; 100(4):931-41. PubMed ID: 9259593
[TBL] [Abstract][Full Text] [Related]
18. Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
Kiwanuka E; Barazzoni R; Tessari P
Diabetes Nutr Metab; 2001 Dec; 14(6):315-24. PubMed ID: 11853363
[TBL] [Abstract][Full Text] [Related]
19. The pancreatic glucagon and C-peptide secretion during hyperinsulinemia in euglycemic glucose clamp with or without somatostatin infusion in normal man.
Wu MS; Ho LT
Horm Metab Res; 1987 Jun; 19(6):253-6. PubMed ID: 2887501
[TBL] [Abstract][Full Text] [Related]
20. Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon.
Shulman GI; Liljenquist JE; Williams PE; Lacy WW; Cherrington AD
J Clin Invest; 1978 Aug; 62(2):487-91. PubMed ID: 670404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
